Humoral and T-cell immune response against SARS-CoV-2 in children with acute respiratory infections
- 14 May 2025
- journal article
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (2) , 45-51
Abstract
Objective. The aim was to evaluate specific T-cell and antibodies against SARS-CoV-2 in children hospitalized with respiratory infectious diseases.Materials and methods. Examination of 121 children was carried out in 2021–2024. Among them 22% of patients were under 1 year of age, 33% — 1–3 years, 21% 4–6 years, 24% 7–14 years. In 51 children acute respiratory infection was concomitant with the course of pertussis. Diagnosis of acute respiratory viral infections was based on clinical data and on PCR testing of nasopharyngeal mucus including PCR testing for SARS-CoV-2. Using a method we developed, memory T cells specific to the SARS-CoV-2 S-glycoprotein were assessed in patients' blood. IgG- and IgM-antibodies to SARS-CoV-2 S-glycoprotein in blood serum were also tested.Results. IgG antibodies to S-glycoprotein SARS-CoV-2 were detected in the blood of 55% of children in 2021, 65% in 2022, 82% in 2023, and 96% in 2024. T lymphocytes activated by stimulation with recombinant S-glycoprotein SARS-CoV-2 were detected in the blood of 25% of children in 2021, 70% in 2022 and 19–35% in 2023–2024. A significant (55%) frequency of serologic markers of transmitted undiagnosed COVID-19 was found in children under 3 years of age whose contacts, especially in 2021, were limited to family. In the groups of patients 3–14 years old, even more children were seropositive (95–100%). Memory T cells were found less frequently in children younger 3 years than after 3 years of age.Conclusion. Examination of individuals with various respiratory diseases can clarify ideas about what part of the population has acquired immunity against SARS-CoV-2, as well as assess the role of memory T cells and antibodies to “ancestral” and current strains of SARS-CoV-2 in limiting morbidity.Keywords
This publication has 16 references indexed in Scilit:
- Algorithm for assessing the level of T cell immune response against SARS-CoV-2 and the results of its application in unvaccinated and vaccinated people who have been infected with COVID-19Russian Journal of Infection and Immunity, 2024
- SARS-CoV-2 seroprevalence among children in Greece during Omicron variant periodEuropean Journal of Pediatrics, 2024
- SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022Infection, 2023
- Maintaining immunological memory to the SARS-CoV-2 virus during COVID-19 pandemicRussian Journal of Infection and Immunity, 2023
- Diversity of immune responses in children highly exposed to SARS-CoV-2Frontiers in Immunology, 2023
- SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominanceEpidemiology and Infection, 2022
- Cellular immunity in patients with COVID-19: molecular biology, pathophysiology, and clinical implicationsJournal of Clinical Practice, 2022
- Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infectionNature Immunology, 2021
- Indicators of the Immune Status in Children after a New Coronavirus InfectionActa Biomedica Scientifica, 2021
- SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinningsPathology, 2020